Aziyo Biologics grants LeMaitre exclusive US distribution rights for cardiovascular products

ELUTIA INC.

Three-year exclusive US distribution deal for ProxiCor PC, ProxiCor CTR, Tyke, and VasCure.
LeMaitre has an exclusive option to acquire the product line after year one; price based on multiple of trailing 12-month sales.
Initial purchase and minimum purchase volumes start Oct 1, 2023; prices subject to annual adjustment.
Aziyo CEO cites focus on CanGaroo Envelope for implantable electronic devices after this partnership.
LeMaitre President says the deal adds next-gen extracellular matrix patches to its US product offering.

item 1.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

ELUTIA INC. entered into Distribution Agreement with LeMaitre Vascular, Inc. (effective 2023-04-20).

Action: entry
Agreement: supply
Counterparty: LeMaitre Vascular, Inc.
Effective: 2023-04-20

Exact text from the filing

On April 20, 2023, Aziyo Biologics, Inc. (the “Company” or “Aziyo”) entered into a Distribution Agreement (the “Agreement”) with LeMaitre Vascular, Inc., a Delaware corporation (“LeMaitre”).

View on SEC.gov

Browse all material agreements →

ELUTIA INC. filing history →

Source: SEC EDGAR

accession 0001558370-23-006381

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.